Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells-Reference-Cited by-同舟云学术

Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells

Published:2022-01 Issue:1 Volume:11 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin & Trans Imm

Author:

Kaeuferle Theresa¹²,Stief Tanja A¹²,Canzar Stefan³,Kutlu Nayad N¹,Willier Semjon¹,Stenger Dana¹,Ferrada‐Ernst Paulina¹,Habjan Nicola¹,Peters Annika E¹,Busch Dirk H²⁴,Feuchtinger Tobias¹²^ORCID

Affiliation:

1. Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation Dr. von Hauner Children’s Hospital University Hospital, LMU Munich Munich Germany

2. German Center for Infection Research (DZIF) Munich Germany

3. Gene Center Ludwig Maximilians University of Munich Munich Germany

4. Institute for Medical Microbiology, Immunology and Hygiene Technische Universität München (TUM) Munich Germany

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1372

Reference30 articles.

1. Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

2. Adoptive T-cell therapy for cancer: The era of engineered T cells